STOCK TITAN

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, announced that its CEO, Rob Claypoole, will present at the 43rd Annual J.P. Morgan Healthcare Conference.

The presentation is scheduled for Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET). A live webcast, including a Q&A session, will be accessible on the Investors section of the Bioventus website. This webcast will be available until February 15, 2025.

Bioventus (Nasdaq: BVS), un leader globale nelle innovazioni per la guarigione attiva, ha annunciato che il suo CEO, Rob Claypoole, presenterà alla 43ª Conferenza Annuale J.P. Morgan Healthcare.

La presentazione è programmata per mercoledì 15 gennaio 2025, alle 10:30 a.m. PT (1:30 p.m. ET). Una diretta streaming, comprensiva di una sessione di domande e risposte, sarà disponibile nella sezione Investitori del sito web di Bioventus. Questa diretta sarà accessibile fino al 15 febbraio 2025.

Bioventus (Nasdaq: BVS), un líder mundial en innovaciones para la curación activa, anunció que su CEO, Rob Claypoole, presentará en la 43ª Conferencia Anual J.P. Morgan Healthcare.

La presentación está programada para miércoles 15 de enero de 2025, a las 10:30 a.m. PT (1:30 p.m. ET). Una transmisión en vivo, que incluirá una sesión de preguntas y respuestas, será accesible en la sección de Inversores del sitio web de Bioventus. Esta transmisión estará disponible hasta el 15 de febrero de 2025.

Bioventus (Nasdaq: BVS), 능동적 치유를 위한 혁신의 글로벌 리더는 CEO인 Rob Claypoole이 제43회 연례 J.P. Morgan Healthcare 컨퍼런스에서 발표할 것이라고 발표했습니다.

발표는 2025년 1월 15일 수요일, 오전 10:30 PT (오후 1:30 ET)에 예정되어 있습니다. 실시간 웹캐스트와 함께 Q&A 세션이 Bioventus 웹사이트의 투자자 섹션에서 이용 가능할 것입니다. 이 웹캐스트는 2025년 2월 15일까지 이용 가능합니다.

Bioventus (Nasdaq: BVS), un leader mondial dans les innovations pour la guérison active, a annoncé que son PDG, Rob Claypoole, fera une présentation lors de la 43e Conférence Annuelle J.P. Morgan Healthcare.

La présentation est prévue pour mercredi 15 janvier 2025, à 10h30 PT (13h30 ET). Une diffusion en direct, incluant une session de questions-réponses, sera accessible dans la section Investisseurs du site web de Bioventus. Cette diffusion sera disponible jusqu'au 15 février 2025.

Bioventus (Nasdaq: BVS), ein weltweit führendes Unternehmen in der Innovation für aktives Heilen, hat bekannt gegeben, dass sein CEO, Rob Claypoole, auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz präsentieren wird.

Die Präsentation ist für Mittwoch, den 15. Januar 2025, um 10:30 Uhr PT (13:30 Uhr ET) angesetzt. Ein Live-Stream, einschließlich einer Q&A-Session, wird im Bereich Investoren der Bioventus-Website verfügbar sein. Dieser Live-Stream wird bis zum 15. Februar 2025 zugänglich sein.

Positive
  • None.
Negative
  • None.

DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET).

The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available until February 15, 2025.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com


FAQ

When will Bioventus present at the J.P. Morgan Healthcare Conference?

Bioventus will present on January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET).

Who is presenting for Bioventus at the J.P. Morgan Healthcare Conference?

Rob Claypoole, the CEO of Bioventus, will be presenting.

How can I access the Bioventus presentation at the J.P. Morgan Healthcare Conference?

The live webcast of the presentation, including Q&A, can be accessed on the Investors section of the Bioventus website.

Until when is the Bioventus presentation webcast available?

The webcast will be available until February 15, 2025.

What time is the Bioventus presentation at the J.P. Morgan Healthcare Conference in Eastern Time?

The presentation will be at 1:30 p.m. ET.

What is the stock symbol for Bioventus?

The stock symbol for Bioventus is BVS.

Bioventus Inc.

NASDAQ:BVS

BVS Rankings

BVS Latest News

BVS Stock Data

606.61M
57.79M
11.56%
69.85%
1.49%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
DURHAM